Jailendra Singh
Stock Analyst at Truist Securities
(1.63)
# 3,664
Out of 4,829 analysts
170
Total ratings
70%
Success rate
-7.66%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAY Waystar Holding | Maintains: Buy | $45 → $50 | $40.25 | +24.22% | 2 | May 8, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $333 → $300 | $313.74 | -4.38% | 4 | Apr 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $263 → $216 | $156.13 | +38.35% | 15 | Apr 10, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $262 → $208 | $140.22 | +48.34% | 9 | Apr 10, 2025 | |
| PRVA Privia Health Group | Maintains: Buy | $27 → $28 | $25.06 | +11.73% | 7 | Apr 10, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $39 → $33 | $55.21 | -40.23% | 9 | Apr 10, 2025 | |
| GDRX GoodRx Holdings | Maintains: Hold | $6.5 → $5.5 | $4.35 | +26.44% | 12 | Apr 10, 2025 | |
| EVH Evolent Health | Maintains: Buy | $15 → $14 | $9.31 | +50.38% | 5 | Apr 10, 2025 | |
| DOCS Doximity | Maintains: Hold | $65 → $58 | $61.04 | -4.98% | 7 | Apr 10, 2025 | |
| AMWL American Well | Maintains: Hold | $12 → $7.5 | $7.21 | +4.02% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $28.54 | +61.18% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $241.44 | -13.02% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $34 | $26.05 | +30.52% | 5 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $26 → $19 | $22.00 | -13.64% | 9 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $10 | $7.35 | +36.05% | 15 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $13.30 | +5.26% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $2.97 | +118.86% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $5.58 | +132.97% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $7.15 | +501.40% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $3.58 | +570.39% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $2.35 | +70.21% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $148.62 | -60.97% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $8.13 | +453.51% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $687.52 | -51.57% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $3.47 | +159.37% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $23.01 | - | 3 | Jan 15, 2021 |
Waystar Holding
May 8, 2025
Maintains: Buy
Price Target: $45 → $50
Current: $40.25
Upside: +24.22%
Medpace Holdings
Apr 23, 2025
Maintains: Hold
Price Target: $333 → $300
Current: $313.74
Upside: -4.38%
IQVIA Holdings
Apr 10, 2025
Maintains: Buy
Price Target: $263 → $216
Current: $156.13
Upside: +38.35%
ICON Public Limited Company
Apr 10, 2025
Maintains: Buy
Price Target: $262 → $208
Current: $140.22
Upside: +48.34%
Privia Health Group
Apr 10, 2025
Maintains: Buy
Price Target: $27 → $28
Current: $25.06
Upside: +11.73%
Hims & Hers Health
Apr 10, 2025
Maintains: Hold
Price Target: $39 → $33
Current: $55.21
Upside: -40.23%
GoodRx Holdings
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $4.35
Upside: +26.44%
Evolent Health
Apr 10, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $9.31
Upside: +50.38%
Doximity
Apr 10, 2025
Maintains: Hold
Price Target: $65 → $58
Current: $61.04
Upside: -4.98%
American Well
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $7.21
Upside: +4.02%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $28.54
Upside: +61.18%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $241.44
Upside: -13.02%
Dec 11, 2024
Maintains: Buy
Price Target: $31 → $34
Current: $26.05
Upside: +30.52%
Nov 13, 2024
Downgrades: Hold
Price Target: $26 → $19
Current: $22.00
Upside: -13.64%
Aug 2, 2024
Maintains: Hold
Price Target: $15 → $10
Current: $7.35
Upside: +36.05%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $13.30
Upside: +5.26%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $2.97
Upside: +118.86%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $5.58
Upside: +132.97%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $7.15
Upside: +501.40%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $3.58
Upside: +570.39%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $2.35
Upside: +70.21%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $148.62
Upside: -60.97%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $8.13
Upside: +453.51%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $687.52
Upside: -51.57%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $3.47
Upside: +159.37%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $23.01
Upside: -